Skip to main content

Peer Review reports

From: Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates

Original Submission
20 Mar 2022 Submitted Original manuscript
30 Mar 2022 Author responded Author comments - Shampa Anupurba
1 Apr 2022 Author responded Author comments - Shampa Anupurba
Resubmission - Version 2
30 Mar 2022 Submitted Manuscript version 2
6 Apr 2022 Author responded Author comments - Shampa Anupurba
Resubmission - Version 3
6 Apr 2022 Submitted Manuscript version 3
17 Apr 2022 Reviewed Reviewer Report
4 May 2022 Reviewed Reviewer Report
2 Jun 2022 Reviewed Reviewer Report - Yash Gupta
19 Jun 2022 Author responded Author comments - Shampa Anupurba
Resubmission - Version 4
19 Jun 2022 Submitted Manuscript version 4
21 Jun 2022 Author responded Author comments - Shampa Anupurba
Resubmission - Version 5
21 Jun 2022 Submitted Manuscript version 5
22 Jun 2022 Author responded Author comments - Shampa Anupurba
Resubmission - Version 6
22 Jun 2022 Submitted Manuscript version 6
8 Jul 2022 Author responded Author comments - Shampa Anupurba
Resubmission - Version 7
8 Jul 2022 Submitted Manuscript version 7
25 Jul 2022 Reviewed Reviewer Report - Yash Gupta
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
16 Aug 2022 Editorially accepted
3 Oct 2022 Article published 10.1186/s12866-022-02622-x

You can find further information about peer review here.

Back to article page